Literature DB >> 14692159

Torsades de pointes following cardioversion: case history and literature review.

Doug Spearritt1.   

Abstract

Torsades de pointes (TDP) is a relatively uncommon but potentially fatal cardiac arrhythmia which occurs in patients with long QT syndromes (LQTS). This literature review and case history investigate the causes, symptoms, presentation and treatment of torsades, focusing on drug induced torsades developing after successful cardioversion. In torsades, imbalanced positive ion flows result in early after-depolarisations (EADs) and increased variability in repolarisation rates. These combine to create an unstable re-entrant polymorphic ventricular tachycardia (VT) which can cause patients to suffer symptoms progressing from syncope to ventricular fibrillation (VF) arrest. Typically, torsades has a twisting morphological presentation on rhythm strips due to the irregularity of its re-entry pattern. The arrhythmia is more common in women. Intravenous magnesium is the initial emergency treatment in torsades. The case history illustrates the progressive acquisition of risk factors for drug induced torsades in a patient treated with sotalol following cardioversion. Typical progressive rhythm strip, electrocardiograph (ECG), and QT & corrected QT interval (QTc) interval changes occurring with the arrhythmia are presented.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14692159     DOI: 10.1016/s1036-7314(05)80037-2

Source DB:  PubMed          Journal:  Aust Crit Care        ISSN: 1036-7314            Impact factor:   2.737


  3 in total

1.  Survival after prolonged resuscitation with 99 defibrillations due to Torsade De Pointes cardiac electrical storm: a case report.

Authors:  Anders Rostrup Nakstad; Christian Eek; Dag Aarhus; Anne Larsen; Kristina Hermann Haugaa
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2010-02-06       Impact factor: 2.953

2.  QTc Dynamics Following Cardioversion for Persistent Atrial Fibrillation.

Authors:  Arwa Younis; Nofrat Nehoray; Michael Glikson; Christopher Bodurian; Eyal Nof; Nicola Luigi Bragazzi; Michael Berger; Wojciech Zareba; Ilan Goldenberg; Roy Beinart
Journal:  Front Cardiovasc Med       Date:  2022-06-03

Review 3.  Efficacy of class III antiarrhythmics and magnesium combination therapy for atrial fibrillation.

Authors:  Amy Wang
Journal:  Pharm Pract (Granada)       Date:  2012-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.